Mesa Laboratories Inc: (NASD: MLAB)
$53.15
1.19 (2.29%)
Volume 739
May 23 09:47 AM ET
Zacks Rank: NA 
| |
Overview Quote
Stock Activity
| Day Low - High | 51.54 - 53.15 |
| 52wk Low - High | 38.64 - 57.00 |
| Previous Close | 51.96 |
| Avg. Volume | 23,045 |
| Industry | MED INSTRUMENTS |
| Market Cap | 175.63 M |
| Div - Yield | 0.56 - 1.08 |
| Beta | 0.37 |
| PE (Forward) | 0.00 |
| Current Year Est. | 0.00 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
|
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
121 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | NA |
| PEG Ratio | NA |
| Current Year Est. | NA |
| Current Quarter Estimate | NA |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 05-22-2013 |
| EPS Last Year | 2.78 |
| Expected Earnings Growth | NA |
Company Description
MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (ND) |
Next Qtr (ND) |
Current Year (ND) |
Next Year (ND) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | NA | NA |
| Number of Estimates | NA | NA | NA | NA |
| Low Estimate | NA | NA | NA | NA |
| High Estimate | NA | NA | NA | NA |
| Year Ago EPS | NA | NA | NA | NA |
| EPS Growth | NA | NA | NA | NA |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| NATUS MEDICAL | BABY | 14.05 | |
|
| CRYOLIFE INC | CRY | 6.31 | |
|
| DELCATH SYS INC | DCTH | 0.42 | |
|
| GLOBUS MEDICAL | GMED | 15.29 | |
|
| HEARTWARE INTL | HTWR | 92.81 | |
|
| MELA SCIENCES | MELA | 1.08 | |
|
| OXYSURE SYSTEMS | OXYS | 0.81 | |
|
| PACIFIC BIOSCI | PACB | 2.45 | |
|
| SUNSHINE HEART | SSH | 5.88 | |
|
| ABIOMED INC | ABMD | 21.83 | |
|
Sector:Medical>> Industry:MED INSTRUMENTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
The Zacks Analyst Blog Highlights: Thoratec, HeartWare, Merit Medical, Mesa Laboratories and Cantel Medical
Dec 13, 2012
Thoratec Soars to 52-Week High
Dec 12, 2012
FDA Clears Teleflex's Latest PICC
Jul 03, 2012
Teleflex Acquires Semprus BioSciences
Jun 26, 2012
FDA Clears Teleflex's Catheter
May 31, 2012
Delcath Prices Stock and Warrants
May 29, 2012
Mesa Reports Better
May 25, 2012
Report for MLAB
Apr 04, 2013
Financials
| EPS TTM | 2.78 |
| Sales | 38 |
| Net Income | 8 |
| Price/Earnings | 18.69 |
| Price/Book | 3.48 |
| Price/Cash Flow | 15.12 |
| Price/Sales | 3.98 |
News
Mesa Laboratories Inc.Corporate Event Announcement Notice - Wall Street Horizon
May 14, 2013
Mesa Laboratories Inc.Corporate Event Announcement Notice - Wall Street Horizon
May 13, 2013
Mesa Laboratories Inc.Corporate Event Announcement Notice - Wall Street Horizon
May 4, 2013
Mesa Laboratories Inc.Corporate Event Announcement Notice - Wall Street Horizon
May 3, 2013
Highest Operating Margin in the Electronic Equipment & Instruments Industry Detected for Mesa Laboratories (MLAB, FEIC, HOLI) - Financial News Network Online - News Corner
Apr 29, 2013
Itron Inc is Among the Companies in the Electronic Equipment & Instruments Industry With the Highest Free Cash Flow Per Share (ITRI, MLAB, MTSC) - Financial News Network Online - News Corner
Apr 26, 2013
Mesa Labs Declares Quarterly Dividend - Close-Up Media
Apr 23, 2013
Mesa Laboratories Inc's board announces USD0.14 per share dividend - M2
Apr 18, 2013
Broker Recommendations
| Current ABR | 1.00 |
| ABR (Last Week) | 1.00 |
| # of recs in ABR | 2 |
| Average Target Price | 59.00 |
| Industry Rank by ABR | 121 out of 265 |
| Rank in Industry | NA |
